semaglutide chinese translation China's weight-loss drug makers take on global giants as Novo Nordisk patent expires The upcoming expiry of the

The FDA-approved prescribing information for all GLP-1 medications includes specific titration schedules designed to minimize gastrointestinal side effects

Most patients experience general nausea in the first 48 weeks as their body adjusts to the medication, but then that baseline nausea fades

GIP receptors exist in fat tissue, bone, and the brain

Advanced tracking With weight, daily activity, and nutritional targets, plus injections and side effects

Common side effects associated with retatrutide consistent with the broader GLP-1 receptor agonist class, as described in the Summary of Product Characteristics (SmPC) for licensed medicines such as Wegovy (semaglutide 2.4 mg) and Mounjaro (tirzepatide) include: Nausea (particularly during dose escalation) Vomiting Diarrhoea or constipation Decreased appetite Injection site reactions such as mild redness or discomfort Increased heart rate , which has been observed with incretin-based therapies These gastrointestinal effects are typically most pronounced when starting treatment or increasing the dose, and they often improve over time as the body adjusts

For complete instructions, see our guide on injecting tirzepatide with a syringe